Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recombinant Zoster Vaccine”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Post-approval studies (Phase 4)UnknownNCT04748939
What this trial is testing

Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT

Who this might be right for
Herpes Zoster
Tuen Mun Hospital 140
Post-approval studies (Phase 4)UnknownNCT03493776
What this trial is testing

Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Who this might be right for
Varicella Zoster Vaccine
Deepali Kumar 50
Post-approval studies (Phase 4)Looking for participantsNCT07502560
What this trial is testing

Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Who this might be right for
Herpes Zoster
GlaxoSmithKline 33,609
Large-scale testing (Phase 3)Active Not RecruitingNCT05371080
What this trial is testing

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Who this might be right for
Herpes Zoster
GlaxoSmithKline 3,038
Testing effectiveness (Phase 2)Study completedNCT04047979
What this trial is testing

Systems Biology of Zoster Vaccine

Who this might be right for
ZosterZoster VaricellaShingles+1 more
Emory University 38
Not applicableLooking for participantsNCT06262776
What this trial is testing

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Who this might be right for
ImmunosuppressionVaccine Response Impaired
Central Adelaide Local Health Network Incorporated 160
Early research (Phase 1)Active Not RecruitingNCT05636436
What this trial is testing

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148
What this trial is testing

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster (HZ)ShinglesVZV+1 more
Guangzhou Patronus Biotech Co., Ltd. 840
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Not applicableEnded earlyNCT03993717
What this trial is testing

Solid Organ Transplant SHINGRIX

Who this might be right for
Kidney Transplant; Complications
Emory University 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT06654700
What this trial is testing

Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 1,200
Large-scale testing (Phase 3)Active Not RecruitingNCT06447779
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 25,000
Post-approval studies (Phase 4)Active Not RecruitingNCT05575830
What this trial is testing

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Who this might be right for
RZV Vaccine (Shingrix ®)
Calmy Alexandra 225
Not applicableLooking for participantsNCT07534007
What this trial is testing

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

Who this might be right for
RZV Vaccine (Shingrix ®)
Fondazione IRCCS Policlinico San Matteo di Pavia 150
Early research (Phase 1)Study completedNCT05991427
What this trial is testing

Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Who this might be right for
Herpes Zoster
CanSino Biologics Inc. 65
Early research (Phase 1)Study completedNCT05769049
What this trial is testing

The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)

Who this might be right for
Herpes Zoster
Jiangsu Rec-Biotechnology Co., Ltd. 48
Early research (Phase 1)Study completedNCT02114333
What this trial is testing

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Who this might be right for
ShinglesHerpes Zoster
University of Colorado, Denver 160
Post-approval studies (Phase 4)Enrolling By InvitationNCT06162494
What this trial is testing

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Who this might be right for
Varicella Zoster
Ann & Robert H Lurie Children's Hospital of Chicago 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443709
What this trial is testing

Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation

Who this might be right for
Zoster; Herpes
Oriol Manuel 75
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Next Page